This handout image obtained September 20, 2024 courtesy of AstraZeneca shows the FDA approved intranasal FluMist Influenza vaccine. No doctor? No problem.
In a first, the US Food and Drug Administration on September 20 approved a nasal spray flu vaccine for self-administration.
Starting next fall, AstraZeneca's FluMist, which was initially authorized in 2003, will be available through an online pharmacy, which will determine eligibility based on a screening assessment, then prescribe and ship the needle-free spray.
"Today's approval of the first influenza vaccine for self- or caregiver-administration provides a new option for receiving a safe and effective seasonal influenza vaccine potentially with greater convenience, flexibility and accessibility for individuals and families," said the FDA's Peter Marks. (Photo by AstraZeneca / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO / HANDOUT / AstraZeneca" - NO MARKETING NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS